Expression of CD68 + Cells in Synovial Tissue from Patients with PsA and its Association with Disease Activity Indices: A Clinical Pilot Study
Open Access
- 1 November 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 21 (5) , 562-569
Abstract
Introduction: Investigating CD68+ positive cells in the synovial tissue is crucial for understanding the pathogenesis of psoriatic arthritis (PsA) and developing targeted treatment strategies. The role of CD68+ positive cells in the synovial tissue of patients with PsA for joint destruction has not been fully studied. Objective: The objective of the study was to examine the presence of CD68+ cells in the synovial tissue of patients with PsA, particularly those with high inflammatory activity. Methods: Synovial tissue samples were collected during knee joint replacement surgeries from patients with PsA (16 patients) and gonarthrosis (25 patients). Immunohistochemical methods were employed to detect CD68+ cell expression in the tissue samples. The results were analyzed by histologists, and the staining intensity and percentage of positively stained cells were evaluated. The data were then divided into three groups for statistical analysis: negative, weakly positive, and strongly positive histological samples. Routine indices for disease activity, VAS, DAPSA, PASDAI, and mCPDAI were used to assess PsA activity in all patients and to assess correlations with CD68+ positive cells in the synovial tissue. Statistical analysis was performed using SPSS version 26.0 (SPSS Inc., Chicago, IL, USA). Results: The expression of CD68+ positive cells was significantly higher in patients with PsA compared to those with activated gonarthrosis (p < 0.001). The indices for disease activity, VAS, DAPSA, PASDAI, mCPDAI, and mCPDAI showed a significant positive relationship with the expression of CD68 + cells on synovial tissue in patients with PsA (p < 0.01) Conclusion: The findings of the study confirm the increased numbers of CD68+ cells in PsA vs. gonathrosis synovium. This suggests the need to explore therapeutic approaches aimed at suppressing or blocking CD68+ cells to potentially mitigate joint damage.Keywords
This publication has 20 references indexed in Scilit:
- Assessment of serum and synovial fluid MMP-3 and MPO as biomarkers for psoriatic arthritis and their relation to disease activity indicesRheumatology International, 2022
- Psoriatic Arthritis: What is Happening at the Joint?Rheumatology and Therapy, 2019
- Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA scoreAnnals of the Rheumatic Diseases, 2016
- The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)Annals of the Rheumatic Diseases, 2013
- Development of a preliminary composite disease activity index in psoriatic arthritisAnnals of the Rheumatic Diseases, 2011
- Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2005
- Immunohistological analysis of synovial tissue for differential diagnosis in early arthritisRheumatology, 1999
- Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritisArthritis & Rheumatism, 1999
- Cutaneous lymphocyte antigen‐positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritisArthritis & Rheumatism, 1996
- Synovial tissue macrophage populations and articular damage in rheumatoid arthritisArthritis & Rheumatism, 1996